International BBB Consortium

The International Blood-Brain Barrier  (BBB) Consortium is directed from OHSU, and combines basic science, research and comprehensive patient care to treat patients with brain tumors.

OHSU has developed protocols and guidelines for opening the blood-brain barrier with input from the universities participating in the International BBB Consortium.

Coordinator

The International BBB Consortium is coordinated from OHSU by Nancy Doolittle, Ph.D., R.N.

Included universities and foundations

Ohio State University Medical Center
Department of Neurosurgery
Columbus, Ohio
Program Director
John McGregor, M.D., 614-293-5440
Clinical Study Coordinator
Susan Bell, R.N., M.S., 614-293-3143

Cleveland Clinic Foundation 
Cleveland, Ohio
Program Director
Gene H. Barnett, M.D., 216-445-1379

Good Samaritan Hospital, Hatton Institute
Cincinnati, Ohio
Program Director
Robert Albright, M.D., 513-936-5370
Clinical Study Coordinator
Nancee Albright, R.N., 513-862-2251

University of Oklahoma Health Science Center
Oklahoma City, Oklahoma
Program Director

Mary Kay Gumerlock, M.D., 405-271-4912
Clinical Study Coordinator
Carol Young, R.N., 405-271-4912

University of Minnesota
Minneapolis, Minnesota
Program Director

Matthew Hunt, M.D., 612-626-0975
Clinical Study Coordinator
Katie Halbert, R.N., 612-624-8117

Hadassah-Hebrew University Medical Center
Jerusalem, Israel
Program Director
Tali Siegal, M.D., 972 2 677-6951 

University of Kentucky 
Lexington, Kentucky
Program Director

Byron Young, M.D., 859-323-5864

Centre Hospital Universitaire de Sherbrooke
Quebec, Canada
Program Director
David Fortin, M.D., 819-346-1110

Map of university partners who are part of the International Blood-Brain Barrier Consortium